Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Concomitant vs Sequential TDV and YF-17D
NCT03342898Phase 3Completed
- Sponsor
- Takeda
- Start
- Feb 2018
- Primary completion
- May 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of dengue tetravalent vaccine (live, attenuated) in dengue fever, sponsored by Takeda. Started Feb 2018; status: completed.
02
Drugs
dengue tetravalent vaccine (live, attenuated)
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT03342898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03342898.